Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: A randomised open-label phase 2 trial

The Lancet Neurology

Volumn 14, Issue 6, 2015, Pages 606-614

  Compter, Annette ^a   van der Worp, H Bart ^a   Schonewille, Wouter J ^b   Vos, Jan Albert ^b   Boiten, Jelis ^c,f   Nederkoorn, Paul J ^d   Uyttenboogaart, Maarten ^e   Lo, Rob T ^a   Algra, Ale ^a   Kappelle, L Jaap ^a   Moll, F L ^a   Mali, W P T M ^a   a Lycklama Nijeholt G ^f   Reekers, J A ^d   Voorend, J M ^g   van Zwam, W H ^g   van Walderveen, M A ^h   Wermer, M J ^h   Eshghi, O ^e   Bots, M L ⁱ   Defreyne, L ⁱ   Koudstaal, P J ⁱ   van Dijkm, E J ⁱ   Frijns, C J ⁱ   Hofmeijer, J ⁱ   van Buchem, M A ⁱ   Rutgers, D R ⁱ   Velthuis, B K ⁱ   Witkamp, T D ⁱ   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f Haaglanden MC   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Academical Medical Center Amsterdam ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY SURGERY; ARTICLE; ARTIFACT; CAROTID ARTERY STENTING; CEREBELLUM HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CONVENTIONAL ANGIOGRAPHY; DEVICE SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPOPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NETHERLANDS; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT OCCLUSION; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERY; VERTEBRAL ARTERY STENOSIS; VERTEBRAL ARTERY STENTING; VERTEBROBASILAR INSUFFICIENCY; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; ENDOVASCULAR SURGERY; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PROCEDURES; RECURRENT DISEASE; STENT; STROKE; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; STENTS; STROKE; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY;

EID: 84929513137     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00017-4     Document Type: Article

References (24)

1. Marquardt L, Kuker W, Chandratheva A, Geraghty O, Rothwell PM Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain 2009, 132:982-988.
2. Markus HS, van der Worp HB, Rothwell PM Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurol 2013, 12:989-998.
3. Flossmann E, Rothwell PM Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain 2003, 126:1940-1954.
4. Gulli G, Khan S, Markus HS Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke 2009, 40:2732-2737.
5. Gulli G, Marquardt L, Rothwell PM, Markus HS Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke 2013, 44:598-604.
6. Eberhardt O, Naegele T, Raygrotzki S, Weller M, Ernemann U Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg 2006, 43:1145-1154.
7. Stayman AN, Nogueira RG, Gupta R A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke 2011, 42:2212-2216.
8. Antoniou GA, Murray D, Georgiadis GS, et al. Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis. J Vasc Surg 2012, 55:1167-1177.
9. Coward LJ, Featherstone RL, Brown MM Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis. Cochrane Database Syst Rev 2005, 2. Cd000516.
10. Compter A, van der Worp HB, Schonewille WJ, et al. VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial. Trials 2008, 9:65.
11. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
12. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003, 361:107-116. for the Carotid Endarterectomy Trialists' Collaboration.
13. Hofmeijer J, Anema PC, van der Tweel I New algorithm for treatment allocation reduced selection bias and loss of power in small trials. J Clin Epidemiol 2008, 61:119-124.
14. Cloud GC, Markus HS Diagnosis and management of vertebral artery stenosis. QJM 2003, 96:27-54.
15. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006, 368:1239-1247. The SPACE Collaborative Group.
16. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006, 355:1660-1671.
17. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001, 357:1729-1737. CAVATAS investigators.
18. Coward LJ, McCabe DJ, Ederle J, Featherstone RL, Clifton A, Brown MM Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke 2007, 38:1526-1530.
19. Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 2014, 383:333-341. for the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.
20. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011, 365:993-1003.
21. Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012, 43:2682-2688.
22. Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 2015, 313:1240-1248.
23. Bonati LH, Lyrer P, Ederle J, Featherstone R, Brown MM Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 2012, 9. Cd000515.
24. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007, 370:1432-1442. on behalf of the Early use of Existing Preventive Strategies for Stroke (EXPRESS) study.